Digitizing cancer rehabilitation for patients during and after treatment

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to assess the feasibility of implementing digitally supported rehabilitation for cancer patients during and after systemic treatment. It focuses on remote physical rehabilitation to improve quality of life, functional ability, and participation in everyday life. The study addresses barriers such as distance to rehabilitation facilities and heavy treatment schedules that may hinder patient participation. By utilizing telehealth, the research seeks to enhance accessibility to rehabilitation services for cancer survivors, particularly in rural areas.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Diagnosed with cancer (IDC: C00\* - C97\*)
* Feasibility study 1 (early rehab): Participants should receive any systemic chemo/immunotherapy preferably (but not necessarily) with a duration of 8 weeks or more. Recruitment should be at earliest convenience preferably (but not necessarily) within 4 weeks of treatment initiation.
* Feasibility study 2 (rehab@home): Participants should preferably have completed chemotherapy/immunotherapy no more than 6 months ago but may be receiving long-standing maintenance and life-prolonging chemo-/immunotherapy.

Exclusion Criteria:

\- Cognitively unable to give consent to, or participate in, a digital rehabilitation programme as judged by project team staff.

Where it's running

• Zealand Unievrsity Hospital
  Næstved, Denmark Recruiting
• University Medical Center Rostock
  Rostock, Germany Recruiting
• Klaipeda University
  Klaipėda, Lithuania Recruiting
• Medical University of Gdansk
  Gdansk, Poland Recruiting
• Ängelholm Hospital
  Ängelholm, Sweden Recruiting

Study contacts

• Principal investigator: Susanne O Dalton, MD PhD — Zealand University Hospital, Department of Clinical Oncology and Palliative Care
• Study coordinator: Gunn Ammitzbøll, PhD
• Email: gai@regionsjaelland.dk
• Phone: + 45 22 46 27 33

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Oncological rehabilitation program to promote physical activity in cancer patients

  This study is testing a 12-week exercise program to see if it helps cancer patients feel better and improve their quality of life after treatment.

  Recruiting Luzerner Kantonsspital · Lucerne, Canton of Lucerne · NCT06945757

• Gyrotonic exercise for elders with breast cancer and Behcet disease

  We’re testing whether a gyrotonic exercise program helps older people who have both Behcet disease and breast cancer.

  Recruiting Cairo University · Giza, Dokki · NCT07929116

• PECS II vs SPSIP nerve blocks for pain after mastectomy

  This study tests whether two ultrasound-guided nerve blocks (PECS II and SPSIP) differ in how much opioid patients need after mastectomy.

  Recruiting Bursa City Hospital · Nilufer, Bursa · NCT07929090

• CG-7321: a first-in-human test in advanced solid tumors

  We’re testing CG-7321 alone and with fulvestrant to see if it’s safe and tolerable in adults with advanced solid tumors.

  Recruiting at 4 sites Phase 1 Chengdu Cynogen Bio-pharmaceutical Tech. Co., Ltd. · Fuzhou, Fujian and 3 other locations · NCT07923214

• Compare a new endoscopy-assisted breast-conserving surgery with the usual approach

  This study tests whether a new endoscopy-assisted breast-conserving technique can provide similar or better cosmetic outcomes and safety compared with conventional breast-conserving surgery in women with early breast cancer who want to preserve their breast.

  Recruiting Sir Run Run Shaw Hospital · Hangzhou, Zhejiang and 21 other locations · NCT07920094

• Different skin care approaches to prevent skin reactions after mastectomy radiation

  This study tests three standard skin care methods to see which best prevents radiation dermatitis in people who had a mastectomy and are receiving post-mastectomy radiation therapy.

  Recruiting at 7 sites Phase 2 Memorial Sloan Kettering Cancer Center · Basking Ridge, New Jersey and 6 other locations · NCT07918989

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.